Cathie Wood started to build up the position in Rubius Therapeutics in Q3 2018 and continued to invest until Q4 2019. Since then they sold 681 Thousand shares. The investor completely sold their stake between Q1 2020 and Q2 2020.
Avg closing price
Price range
Sold -318 Thousand shares
Q2 2020
Avg closing price
$5.90
Price range
$4.01
-
$6.88
Sold 53.3% shares (-363 Thousand shares)
Q1 2020
Avg closing price
$7.43
Price range
$3.74
-
$9.84
Increased shares by 28.5% (+151 Thousand shares)
Q4 2019
Avg closing price
$9.67
Price range
$7.23
-
$14.12
Increased shares by 68.1% (+214 Thousand shares)
Q1 2019
Avg closing price
$15.35
Price range
$13.27
-
$18.51
Increased shares by 67.4% (+127 Thousand shares)
Q4 2018